By all accounts, Santa Monica-based GoodRx delivered a strong first quarter as a public company. Year-over-year revenue beat analyst expectations, soaring 38%. Monthly active users increased a robust 29%. As the pandemic continued to rage across the United States, a record 4.9 million consumers used GoodRx to fill prescriptions.

"I think across the board I was really happy," said co-founder and CEO Doug Hirsch.

But Wall Street was not as pleased, with the stock closing down more than 6%. After mostly zigzagging since their September debut, shares now trade near where they did the first day of trading.

Read more Show less

Ten years ago, GoodRx CEO Doug Hirsch walked into a pharmacy on Wilshire Boulevard with a prescription that would've cost him $500.

"It seemed outrageous," he said on Tuesday during a wide ranging discussion with dot.LA managing editor Rachel Uranga at the dot.LA Summit.

Read more Show less

Prescription discount GoodRx shares skyrocketed more than 50% in its Wall Street debut on Wednesday. Shares started trading under the symbol "GDRX" at an IPO pricing of $33 each but quickly rose landing at $50.50 per share at market close.

GoodRx is the first Los Angeles tech company to go public this year and follows a wave of other tech companies that have recently gone public, including Unity and Snowflake.

Read more Show less

Trending